Physicochemical and microbiological stability of two new oral liquid formulations of clonidine hydrochloride for pediatric patients

References

• Aceti A, Corvaglia L, Paoletti V, Mariani E, Ancora G, Galletti S, Faldella G. 2009. Protein content and fortification of human milk influence gastroesophageal reflux in preterm infants. J Pediatr Gastroenterol Nutr. 49:613–618.
   PubMed Web of Science ®Google Scholar
• Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA. 2015. Opioid prescription claims among women of reproductive age-United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 64:37–41.
   PubMed Web of Science ®Google Scholar
• Allen LV. 2008. Dosage form design and development. Clin Ther. 30:2102–2111.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. 1976. Commentary on breast-feeding and infant formulas, included proposed standard formulas. Pediatrics. 57:278–285.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. 1997. Committee on Drugs. “Inactive” ingredients in pharmaceutical products: update (subject review). Pediatrics. 99:268–278.
   PubMed Web of Science ®Google Scholar
• Amin Zare M, RazaviRohani SM, Raesi M, Javadu Hosseini SH, Hashemi M. 2014. Antibacterial effects of monolaurin, sorbic acid and potassium sorbate on Staphylococcus aureus and Escherichia coli. J Food Qual Hazards Control. 1:52–55.
   Google Scholar
• Arya SS. 1980. Stability of sorbic acid in aqueous solutions. J Agric Food Chem. 28:1246–1249.
   Web of Science ®Google Scholar
• Bartelink IH, Rademaker C, Schobben A, van den Anker JN. 2006. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet. 45:1077–1097.
   PubMed Web of Science ®Google Scholar
• Bauters T, Claus B, Willems E, De Porre J, Verlooy J, Benoit Y, Robays H. 2012. What’s in a drop? Optimizing strategies for administration of drugs in pediatrics. Int J Clin Pharm. 34:679–681.
   PubMed Web of Science ®Google Scholar
• Brayfield A. 2014. Martindale: the complete drug reference. 38th ed. London: Pharmaceutical Press.
   Google Scholar
• Breitkreutz J, Boos J. 2007. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 4:37–45.
   PubMed Web of Science ®Google Scholar
• Brion F, Nunn AJ, Rieutord A. 2003. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr. 92:486–490.
   PubMed Web of Science ®Google Scholar
• Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JON. 2001. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide. 5:580–586.
   PubMed Web of Science ®Google Scholar
• Castro MP, Gerschenson LN, Campos CA. 2005. Stability of sorbates in the presence of EDTA: effect of pH, packaging material and sequestrant level. J Sci Food Agric. 85:328–332.
   Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Harney J. 2015. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 373:1789–1790.
   PubMed Web of Science ®Google Scholar
• Davies H, Gilbert R, Johnson K, Petersen I, Nazareth I, O'Donnell M, Guttmann A, Gonzalez-Izquierdo A. 2016. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada. Arch Dis Child Fetal Neonatal Ed. 101:26–30.
   Web of Science ®Google Scholar
• European Pharmacopoeia (Ph.Eur.). 2016. Clonidine hydrochloride official monograph. 9th ed. Strasbourg: Council of Europe.
   Google Scholar
• European Medicines Agency (EMA). Committee for Medicinal Products for human use (CHMP). 2005. Reflection paper: formulations of choice for the paediatric population. EMEA/CHMP/PEG/194810/2005.
   Google Scholar
• European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). 2012. Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use. EMA/CHMP/SWP/272921/2012.
   Google Scholar
• de Goede AL, Boedhram RR, Eckhardt M, Hanf LM, Koch BCP, Vermaat CH, Vermes A. 2012. Development and validation of a paediatric oral formulation of clonidine hydrochloride. Int J Pharm. 433:119–120.
   PubMed Web of Science ®Google Scholar
• Ensom MH, Decarie D. 2014. Stability of extemporaneously compounded clonidine in glass and plastic bottles and plastic syringes. Can J Hosp Pharm. 67:308–310.
   PubMedGoogle Scholar
• Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, Cooper WO. 2013. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol. 23:498–503.
   PubMed Web of Science ®Google Scholar
• Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. 2007. Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 59:1043–1055.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). 2014. Questions and answers on benzoic acid and benzoates in 4 the context of the revision of the guideline on “Excipients 5 in the label and package leaflet of medicinal products for 6 human use” (CPMP/463/00).
   Google Scholar
• Feal CB, Barroso PC, Carcelen AJ, Fábrega BC, Gallego LV, Hidalgo AE, Pozas Del Río MT, Puy GM, Revert M-NA, Valverde ME, et al. 2003. Utilización de medicamentos en unidades de neonatología de 6 hospitales españoles. Farmacia Hospitalaria. 27:17–19.
   Google Scholar
• Ferrand C, Marc F, Fritsch P, Cassand P, de Saint Blanquat G. 2000. Mutagenicity and genotoxicity of sorbic acid-amine reaction products. Food Addit Contam. 17(11):895–901.
   PubMed Web of Science ®Google Scholar
• Gomes T, Juurlink DN. 2016. Opioid use and overdose: what we've Learned in Ontario. Healthc Q. 18:8–11.
   PubMedGoogle Scholar
• Haywood A, Glass BD. 2013. Liquid dosage forms extemporaneously prepared from commercially available products – considering new evidence on stability. J Pharm Pharm Sci. 16:441–455.
   PubMed Web of Science ®Google Scholar
• International Council for Harmonisation. 2003. Stability testing of new drug substances. [accessed 2018 Jul 18]. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf
   Google Scholar
• International Council for Harmonisation. 2005. Validation of analytical procedures: text and methodology. [accessed 2018 Jul 18] http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf
   Google Scholar
• Ivanovska V, Rademaker CM, van Dijk L, Mantel-Teeuwisse AK. 2014. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 134:361–372.
   PubMed Web of Science ®Google Scholar
• Jansson LM, Velez M. 2012. Neonatal abstinence syndrome. Curr Opin Pediatr. 24:252–258.
   PubMed Web of Science ®Google Scholar
• Khandelwal GD, Wedzicha B. 1990. Nucleophilic reactions of sorbic acid. Food Addit Contam. 7:685–694.
   PubMed Web of Science ®Google Scholar
• Kheddis B, Bamibah D, Handi M, Perié JJ. 1981. Dihydropyridones-2 dérivés de l´acide sorbique: synthèse et analyse conformationnelle. Bull Sci Chim Fr. 3. 4:135–140.
   Google Scholar
• Krans EE, Cochran G, Bogen DL. 2015. Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations. Clin Obstet Gynecol. 58:370–379.
   PubMed Web of Science ®Google Scholar
• Kyungwha L, Azlin M. 2004. Effects of cetylpuridinium chloride, acidified sodium chlorite, and potassium sorbate on populations of Escherichia coli O157:H7, Listeria monocytogenes, and Staphylococcus aureus on fresh beef. J Food Prot. 67:310–315.
   PubMed Web of Science ®Google Scholar
• Le Guennec JC, Paré C, Billon B. 1983. Hyperosmolar formulas in necrotizing enterocolitis. Am J Dis Child. 137:506.
   PubMedGoogle Scholar
• Levinson ML, Johnson CE. 1992. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid. Am J Hosp Pharm. 49:122–125.
   PubMedGoogle Scholar
• Lieberman S, Enig MG, Preuss HG. 2006. A review of monolaurin and lauric acid: natural virucidal and bactericidal agents. Altern Complem Ther. 12:310–314.
   Google Scholar
• Ma C, Decarie D, Ensom MH. 2014. Stability of clonidine suspension in oral plastic syringes. Am J Health Syst Pharm. 71:657–661.
   PubMed Web of Science ®Google Scholar
• Muro-Brussi M. 2004. Ensayos clínicos en niños. Nuevo Real Decreto, viejos conceptos. An Pediatr. 61:387–389.
   Google Scholar
• Nahata MC, Allen LV. 2008. Extemporaneous drug formulations. Clin Ther. 30:2112–2119.
   PubMed Web of Science ®Google Scholar
• Oh D, Marshall DL. 1994. Enhanced inhibition of Listeria monocytogenes by glycerol monolaurate with organic acids. J Food Sci. 59:1258–1261.
   Web of Science ®Google Scholar
• Ortigosa GS, López VM, Díaz LF, Castejón PE, Caballero RA, Carreras CR, Mur SA. 2011. Consumo de drogas durante la gestación y su repercusión neonatal. Análisis de los períodos 1982-1988 y 2002-2008. Medicina Clínica. 136:423–430.
   PubMedGoogle Scholar
• Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. 2012. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000. JAMA. 307:20091934–20091940.
   Web of Science ®Google Scholar
• Patrick SW, Davis MM, Lehmann CU, Lehman CU, Cooper WO. 2015. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 35:650–655.
   PubMed Web of Science ®Google Scholar
• Potier A, Voyat J, Nicolas A. 2017. Stability study of a clonidine oral solution in a novel vehicle designed for pediatric patients. Pharm Dev Technol. 24:1–10. doi: 10.1080/10837450.2017.1389955. [Epub ahead of print].
   PubMedGoogle Scholar
• RFE. Real Farmacopea Española. 2014. Ministerio de Sanidad y Consumo, Agencia Española de Medicamentos y Productos Sanitarios, eds. Madrid.
   Google Scholar
• Salunke S, Giacoia G, Tuleu C. 2012. The STEP (safety and toxicity of excipients for paediatrics) database. Part 1-A need assessment study. Int J Pharm. 435:101–111.
   PubMedGoogle Scholar
• Sauberan JB, Phuong P, Ilog ND, Rossi SS. 2016. Stability and osmolality of extemporaneously prepared clonidine oral liquid for neonates. Ann Pharmacother. 50:243–244.
   PubMed Web of Science ®Google Scholar
• Stephenson T. 2005. How children's responses to drugs differ from adults. Br J Clin Pharmacol. 59:670–673.
   PubMed Web of Science ®Google Scholar
• Stover MW, Davis JM. 2015. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol. 39:561–565.
   PubMed Web of Science ®Google Scholar
• The United States pharmacopeia (USP), Clonidine official monographs, chapters <61>, <62> and <1111>, 40nd rev., and the national formulary. 35th ed. Rockville (MD): United States Pharmacopeial Convention.
   Google Scholar
• Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, Clark RH, Spitzer AR. 2015. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 372:2118–2126.
   PubMed Web of Science ®Google Scholar
• Turner MA, Storme T. 2012. European study for neonatal excipient exposure (ESNEE). Eur J Hosp Pharm. 19:67.
   Google Scholar
• Turner S, Longworth A, Nunn AJ, Choonara I. 1998. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 316:343–345.
   PubMed Web of Science ®Google Scholar
• van Riet-Nales DA, Ferreira JA, Schobben AF, de Neef BJ, Egberts TC, Rademaker CM. 2015. Methods of administering oral formulations and child acceptability. Int J Pharm. 491:261–267.
   PubMed Web of Science ®Google Scholar
• Verbiscar A, Campbell K. 1964. Unsaturated six-membered ring lactams. J Org Chem. 29:2472–2474.
   Web of Science ®Google Scholar
• Warren MD, Miller AM, Traylor J, Bauer A, Patrick SW. 2015. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013. MMWR Morb Mortal Wkly Rep. 64:125–128.
   PubMed Web of Science ®Google Scholar
• Wening K, Breitkreutz J. 2011. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm. 404:1–9.
   PubMed Web of Science ®Google Scholar
• Wening K, Laukamp EJ, Thommes M, Breitkreutz J. 2012. Individual oral therapy with immediate release and effervescent formulations delivered by the solid dosage pen. J Pers Med. 2:217–231.
   PubMedGoogle Scholar
• Whittaker A, Mulla H, Turner MA, Field DJ, Mulla H, Pandya HC. 2009. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed. 94: F236–F240.
   PubMed Web of Science ®Google Scholar
• Yarramraju S, Akurathi V, Wolfs K, Van Schepdael A, Hoogmartens J, Adams E. 2007. Investigation of sorbic acid volatile degradation products in pharmaceutical formulations using static headspace gas chromatography. J Pharmaceut Biomed. 44:456–463.
   PubMed Web of Science ®Google Scholar
• Yazdy MM, Desai RJ, Brogly SB. 2015. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 4:56–70.
   PubMed Web of Science ®Google Scholar